Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

Clinical implications of the intrinsic molecular subtypes of breast cancer

(2015) Aleix Prat et al.   BREAST

Targeting the Androgen Receptor in Breast Cancer

(2015) KeeMing Chia et al.   Current Oncology Reports

Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer

(2014) Jung Eun Choi et al.   ANNALS OF SURGICAL ONCOLOGY

The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping

(2014) Sotiris Lakis et al.   BREAST

Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort

(2014) Karin Elebro et al.   CANCER CAUSES & CONTROL

Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status

(2014) Songmi Noh et al.   TUMOR BIOLOGY

Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype

(2013) Lee J. McGhan et al.   ANNALS OF SURGICAL ONCOLOGY

Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer

(2013) A. Gucalp et al.   CLINICAL CANCER RESEARCH

Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer

(2013) Yukiko Shibahara et al.   HUMAN PATHOLOGY

Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis

(2013) F. E. Vera-Badillo et al.   JNCI-Journal of the National Cancer Institute

Breast cancer: Current and future endocrine therapies

(2013) Carlo Palmieri et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis

(2013) Qing Qu et al.   PLoS One

Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer

(2013) Eriko Tokunaga et al.   Cancer Medicine

Expression of androgen receptors in triple negative breast carcinomas

(2012) Ivana Mrklić et al.   ACTA HISTOCHEMICA

Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers

(2012) Seho Park et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression and clinical significance of androgen receptor in triple negative breast cancer

(2012) Xiang Luo et al.   Chinese Journal of Cancer

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers

(2011) S. Park et al.   ANNALS OF ONCOLOGY

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

(2011) P-L Jerevall et al.   BRITISH JOURNAL OF CANCER

Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer

(2011) Min Ni et al.   CANCER CELL

Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women

(2011) R. Hu et al.   CLINICAL CANCER RESEARCH

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity

(2011) Francini de Mattos Lima Lin et al.   JOURNAL OF CLINICAL PATHOLOGY

The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer

(2011) Dabei Tang et al.   MEDICAL ONCOLOGY

Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray

(2011) Jiehua He et al.   MEDICAL ONCOLOGY

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

(2010) Isabella Castellano et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers

(2010) Donata Micello et al.   VIRCHOWS ARCHIV

Expression of androgen receptors in primary breast cancer

(2009) S. Park et al.   ANNALS OF ONCOLOGY

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

(2009) Francesca De Amicis et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen Receptor Inhibits Estrogen Receptor-  Activity and Is Prognostic in Breast Cancer

(2009) A. A. Peters et al.   CANCER RESEARCH

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

(2009) A. Jansson et al.   CLINICAL CANCER RESEARCH

Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer

(2009) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

(2009) Leo A Niemeier et al.   MODERN PATHOLOGY

Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors

(2008) Elisa J. Cops et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY